Allgens Medical Technology Co. Ltd. A

688613 • SHG

¥15.03-¥0.20 (1.31%)

Estimate

P/E

250.5

EPS

0.06

Beta

0.578

Growth

Revenue, YoY

-3.81%

Net income, YoY

-80.62%

FCF, YoY

-737.9%

Dividends

Dividend yield

0.2%

Annual payout

¥0.03

Next ex. div date

August 6, 27

Payout

11.62%

Div.rating

About the company

Ticker

688613

ISIN

CNE1000051W7

Country

China

Sector (GICS)

Healthcare

Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China. The company offers biomimetic mineralized collagen artificial bone repair products, including Gejin, Chibei, and Lurui, as well as Aoyu Ning; tissue regeneration and repair products; and absorbable collagen hemostatic sponge products. Its products include isometal, cranial ulcer, teeth, dental implants, and bongold. The company was founded in 2004 and is based in Beijing, China.

Frequently asked questions

What sector does Allgens Medical Technology Co. Ltd. A (688613) operate in?

Allgens Medical Technology Co. Ltd. A belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Allgens Medical Technology Co. Ltd. A (688613) current stock price?

As of the latest data, Allgens Medical Technology Co. Ltd. A stock price is CN¥15.03, with a previous close of CN¥15.23. Allgens Medical Technology Co. Ltd. A lost -CN¥0.20 in the last trading session, representing a -1.31% loss.

What is Allgens Medical Technology Co. Ltd. A (688613) current market capitalization?

Allgens Medical Technology Co. Ltd. A market cap is approximately 2.06 billion.

What is Allgens Medical Technology Co. Ltd. A (688613) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.06.

What is Allgens Medical Technology Co. Ltd. A (688613) Price-to-Earnings (P/E) ratio?

Allgens Medical Technology Co. Ltd. A current P/E ratio is 250.5.

Does Allgens Medical Technology Co. Ltd. A (688613) pay dividends?

Yes. Allgens Medical Technology Co. Ltd. A pays annual dividends with an annualized yield of 0.2% and an estimated annual payout of CN¥0.03 per share.

When is the next ex-dividend date for Allgens Medical Technology Co. Ltd. A (688613)?

The next ex-dividend date is scheduled for August 06, 2027.

What is Allgens Medical Technology Co. Ltd. A (688613) beta (volatility) score?

Allgens Medical Technology Co. Ltd. A has a beta of 0.578, indicating lower volatility than the overall market.